Else Nutrition Reports Fiscal Year 2025 Financial Results and Highlights Operational Progress, Strengthened Financial Foundation, and Clear Path Toward Profitability
Go back to Else Nutrition Reports Fiscal Year 2025 Financial Results and Highlights Operational Progress, Strengthened Financial Foundation, and Clear Path Toward Profitability| Natus Medical, Inc. (NASDAQ: BABY) | Delayed: 26.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.75 | 52 Week High | $51.05 | |||
| Open | $13.80 | 52 Week Low | $29.54 | |||
| Day High | $26.75 | P/E | 36.15 | |||
| Day Low | $26.75 | EPS | $0.74 | |||
| Volume | 10,257 | |||||
